AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUL 172 min read$VXRT

Vaxart, Inc. (VXRT): Submission of Matters to a Vote of Security Holders

Vaxart, Inc. (VXRT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. vxrt20260717_8k.htm false 0000072444 0000072444 2026-07-16 2026-07-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event repo

Original reporting
SEC EDGAR 8-K
Published Jul 17, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
$VXRT
Neutral
medium confidence
Mentioned
$VXRT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VXRTNeutralLow
01

Why it matters

This is primarily a corporate governance disclosure: directors were elected, the independent auditor was ratified, and executive compensation received an advisory vote that did not pass.

02

Market read

Traders may treat this as a low-signal governance update unless they are actively trading on governance sentiment or board composition.

03

What to watch

The filing includes broker non-votes and vote-withheld counts; if any director election was close, it could matter for governance expectations, but the text provides no qualitative interpretation.

Relevance 6/10Novelty 3/10Timing: after-hours SEC filing of 8-K vote results (filed July 17, 2026)

Background

The company held its 2026 annual stockholders meeting on July 16, 2026 and reported voting results via SEC Form 8-K.

Company-level read

Ticker impact

$VXRTNeutralMedium confidence
Context

Vaxart filed an 8-K reporting annual meeting results, including director elections, auditor ratification, and a non-binding say-on-pay vote.

Expected impact

Limited near-term impact; any reaction is likely muted unless investors were focused on say-on-pay or board changes.

Evidence & confidence

The filing discloses vote tallies for directors, independent auditor ratification, and a non-binding advisory compensation vote, but provides no new operating, financial, or strategic information.

Market effects

Sector

Minimal; governance vote outcomes do not typically change biotech sector fundamentals.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

If investors were concerned about governance or executive compensation, the say-on-pay vote could influence sentiment even without binding consequences.

Key entities

  • issuer
    Vaxart, Inc.

    OTCQX-listed company filing the 8-K with annual meeting voting results.

  • auditor
    WithumSmith+Brown, PC

    Ratified as independent registered public accounting firm for the year ending December 31, 2026.

Read at source← All news

Related articles

AUG 6
$VXRTMed

Vaxart, Inc. (VXRT): Results of Operations and Financial Condition

Vaxart, Inc. (VXRT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1000406.htm EXHIBIT 99.1 ex_1000406.htm Exhibit 99.1 Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results Reported topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial; Topline data from 400-person sentinel safety c

SEC EDGAR 8-K6 min
JUN 25
$VXRTMed

Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial

Vaxart said it modified its BARDA funding contract via Advanced Technology International to match the current scope of its Phase 2b COVID-19 oral pill vaccine trial. Total available funding is now about $345 million, down ~$116 million after a BARDA partial termination reduced enrollment. The change releases ~$29 million to complete trial and exploratory analyses, enabling 12-month sentinel-cohort data in coming weeks and main-cohort data in 1H 2027.

manilatimes.net3 min
AUG 9
$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

yahoo.com6 min
AUG 9
$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

rttnews.com2 min
AUG 9
$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

rte.ie6 min
AUG 9
$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

yahoo.com6 min